Variant report
Variant | rs7251614 |
---|---|
Chromosome Location | chr19:20959177-20959178 |
allele | C/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:223)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | PML | chr19:20958997-20959227 | GM12878 | blood: | n/a | n/a |
2 | NFYA | chr19:20958812-20959288 | K562 | blood: | n/a | chr19:20959019-20959033 chr19:20959021-20959031 chr19:20959021-20959031 chr19:20959018-20959030 chr19:20959019-20959032 chr19:20959019-20959037 chr19:20959019-20959034 chr19:20959019-20959034 |
3 | PBX3 | chr19:20958709-20959366 | SK-N-SH | brain: | n/a | chr19:20958939-20958948 chr19:20959022-20959031 chr19:20958983-20958992 |
4 | SP2 | chr19:20958806-20959308 | HepG2 | liver: | n/a | chr19:20958996-20959011 chr19:20959022-20959032 |
5 | POLR2A | chr19:20958874-20959437 | GM12878 | blood: | n/a | n/a |
6 | POLR2A | chr19:20958897-20959607 | GM12878 | blood: | n/a | n/a |
7 | POLR2A | chr19:20959132-20959284 | K562 | blood: | n/a | n/a |
8 | IRF3 | chr19:20958846-20959197 | GM12878 | blood: | n/a | chr19:20959000-20959014 chr19:20959021-20959030 |
9 | FOS | chr19:20958863-20959215 | GM12878 | blood: | n/a | chr19:20959023-20959032 |
10 | POLR2A | chr19:20958801-20959656 | GM12878 | blood: | n/a | n/a |
11 | TAF1 | chr19:20958878-20959621 | GM12878 | blood: | n/a | n/a |
12 | TCF3 | chr19:20958984-20959318 | GM12878 | blood: | n/a | n/a |
13 | POLR2A | chr19:20958944-20959284 | SK-N-SH | brain: | n/a | n/a |
14 | IRF4 | chr19:20958942-20959398 | GM12878 | blood: | n/a | n/a |
15 | CHD2 | chr19:20958912-20959333 | HepG2 | liver: | n/a | n/a |
16 | POLR2A | chr19:20958915-20959449 | PANC-1 | pancreas: | n/a | n/a |
17 | POLR2A | chr19:20959015-20959288 | HepG2 | liver: | n/a | n/a |
18 | MXI1 | chr19:20958624-20960125 | SK-N-SH | brain: | n/a | n/a |
19 | POLR2A | chr19:20958821-20959747 | GM12892 | blood: | n/a | n/a |
20 | POLR2A | chr19:20958817-20959601 | H1-neurons | neurons: | n/a | n/a |
21 | E2F4 | chr19:20958910-20959487 | GM12878 | blood: | n/a | chr19:20959430-20959445 chr19:20959095-20959102 chr19:20959021-20959030 chr19:20959095-20959103 chr19:20959095-20959103 chr19:20959094-20959104 chr19:20959094-20959105 |
22 | GATA3 | chr19:20958813-20959252 | MCF-7 | breast: | n/a | n/a |
23 | PML | chr19:20958802-20959483 | GM12878 | blood: | n/a | n/a |
24 | CHD1 | chr19:20959134-20959334 | GM12878 | blood: | n/a | n/a |
25 | TAF1 | chr19:20958868-20959387 | MCF-7 | breast: | n/a | n/a |
26 | POLR2A | chr19:20958941-20959344 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | SIN3AK20 | chr19:20958850-20959438 | HepG2 | liver: | n/a | n/a |
28 | POLR2A | chr19:20959123-20959266 | Hela-S3 | cervix: | n/a | n/a |
29 | SP1 | chr19:20958761-20959367 | GM12878 | blood: | n/a | chr19:20959000-20959012 chr19:20958997-20959011 chr19:20959002-20959011 chr19:20959000-20959012 chr19:20959020-20959041 chr19:20959000-20959011 chr19:20959001-20959010 |
30 | TBP | chr19:20958920-20959440 | K562 | blood: | n/a | n/a |
31 | PAX5 | chr19:20958954-20959268 | GM12878 | blood: | n/a | n/a |
32 | TCF12 | chr19:20958992-20959305 | GM12878 | blood: | n/a | n/a |
33 | MYBL2 | chr19:20958999-20959395 | HepG2 | liver: | n/a | n/a |
34 | FOXM1 | chr19:20958805-20959491 | GM12878 | blood: | n/a | n/a |
35 | POU2F2 | chr19:20958864-20959660 | GM12891 | blood: | n/a | n/a |
36 | POLR2A | chr19:20958868-20959341 | HepG2 | liver: | n/a | n/a |
37 | GABPA | chr19:20958775-20959339 | MCF-7 | breast: | n/a | n/a |
38 | TBP | chr19:20958932-20959326 | HepG2 | liver: | n/a | n/a |
39 | POLR2A | chr19:20958800-20959779 | GM12878 | blood: | n/a | n/a |
40 | POLR2A | chr19:20959138-20959257 | A549 | lung: | n/a | n/a |
41 | SP1 | chr19:20958858-20959282 | K562 | blood: | n/a | chr19:20959000-20959012 chr19:20958997-20959011 chr19:20959002-20959011 chr19:20959000-20959012 chr19:20959020-20959041 chr19:20959000-20959011 chr19:20959001-20959010 |
42 | ELF1 | chr19:20958884-20959322 | SK-N-SH | brain: | n/a | n/a |
43 | USF2 | chr19:20958794-20959273 | HepG2 | liver: | n/a | n/a |
44 | ELF1 | chr19:20958825-20959260 | K562 | blood: | n/a | n/a |
45 | RUNX3 | chr19:20959130-20959553 | GM12878 | blood: | n/a | n/a |
46 | POLR2A | chr19:20958944-20959334 | HepG2 | liver: | n/a | n/a |
47 | MXI1 | chr19:20958846-20959578 | HepG2 | liver: | n/a | n/a |
48 | RELA | chr19:20958926-20959592 | GM15510 | blood: | n/a | n/a |
49 | POLR2A | chr19:20958947-20959607 | GM12878 | blood: | n/a | n/a |
50 | TAF1 | chr19:20958970-20959260 | SK-N-SH | brain: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:20957022..20960457-chr19:20966415..20968798,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZNF66 | TF binding region |
ENSG00000269040 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10401248 | 0.81[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10404392 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10404727 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10406140 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10406291 | 0.89[AFR][1000 genomes];0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10406527 | 0.87[AMR][1000 genomes];0.81[EUR][1000 genomes] |
rs10406929 | 0.96[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10407397 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10408565 | 0.96[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10409460 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10409905 | 0.86[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10410391 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10410834 | 0.93[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10411095 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10411309 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10411707 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10411736 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10413052 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10413183 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10413187 | 1.00[ASN][1000 genomes] |
rs10413400 | 0.81[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10413480 | 0.93[AFR][1000 genomes];0.87[AMR][1000 genomes];0.93[EUR][1000 genomes] |
rs10413812 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10414418 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10414513 | 0.89[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10414532 | 0.89[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10415086 | 0.89[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10416047 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10418060 | 0.84[AFR][1000 genomes] |
rs10420676 | 0.89[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10421506 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10423936 | 0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10424583 | 0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10424677 | 0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10424824 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10424826 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10424930 | 0.89[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10425098 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs10425326 | 0.84[ASN][1000 genomes] |
rs10425936 | 0.84[ASN][1000 genomes] |
rs10426864 | 1.00[ASN][1000 genomes] |
rs11666023 | 0.82[AFR][1000 genomes] |
rs11667650 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11667747 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11668858 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11668917 | 0.87[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11669025 | 0.93[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11669878 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs11669907 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs11669935 | 0.88[AFR][1000 genomes];0.83[ASN][1000 genomes] |
rs11669957 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs11669965 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs11669970 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs11669976 | 0.84[AFR][1000 genomes];0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs11671855 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs12971606 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13343397 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13343468 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13343535 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs13343536 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs13343577 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs13343589 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs13343627 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs13344843 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13345527 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1643761 | 0.82[AFR][1000 genomes] |
rs1643762 | 0.84[AFR][1000 genomes] |
rs1643765 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2545171 | 0.82[AFR][1000 genomes] |
rs2545176 | 0.84[ASN][1000 genomes] |
rs2545177 | 0.84[ASN][1000 genomes] |
rs2545178 | 0.84[ASN][1000 genomes] |
rs2545179 | 0.84[ASN][1000 genomes] |
rs2545180 | 0.84[ASN][1000 genomes] |
rs2545181 | 0.84[ASN][1000 genomes] |
rs2545182 | 0.84[ASN][1000 genomes] |
rs2545183 | 0.84[ASN][1000 genomes] |
rs2545184 | 0.84[ASN][1000 genomes] |
rs2545185 | 0.84[ASN][1000 genomes] |
rs2545186 | 0.84[ASN][1000 genomes] |
rs2545191 | 0.84[ASN][1000 genomes] |
rs2545199 | 0.84[ASN][1000 genomes] |
rs2545209 | 0.84[ASN][1000 genomes] |
rs2545211 | 0.84[ASN][1000 genomes] |
rs2545217 | 0.84[ASN][1000 genomes] |
rs2545224 | 0.84[ASN][1000 genomes] |
rs2547133 | 0.84[ASN][1000 genomes] |
rs2547158 | 0.84[ASN][1000 genomes] |
rs2547160 | 0.84[ASN][1000 genomes] |
rs2547164 | 0.84[ASN][1000 genomes] |
rs2547176 | 0.84[ASN][1000 genomes] |
rs2547177 | 0.84[ASN][1000 genomes] |
rs2547179 | 0.84[ASN][1000 genomes] |
rs2547182 | 0.84[ASN][1000 genomes] |
rs2547183 | 0.84[ASN][1000 genomes] |
rs2560961 | 0.90[AMR][1000 genomes];0.87[EUR][1000 genomes] |
rs2560962 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2560964 | 0.84[ASN][1000 genomes] |
rs28501307 | 0.88[AFR][1000 genomes] |
rs28593054 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs28669723 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs28696188 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs28798674 | 0.84[ASN][1000 genomes] |
rs28809326 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs2909792 | 0.84[ASN][1000 genomes] |
rs35331171 | 0.91[AFR][1000 genomes];0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs35668100 | 0.81[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs36056689 | 0.92[ASN][1000 genomes] |
rs365033 | 0.92[ASN][1000 genomes] |
rs365590 | 0.84[ASN][1000 genomes] |
rs366543 | 0.92[ASN][1000 genomes] |
rs366949 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs367380 | 0.84[ASN][1000 genomes] |
rs367687 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs370551 | 1.00[ASN][1000 genomes] |
rs372292 | 0.82[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs372832 | 0.84[ASN][1000 genomes] |
rs376260 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs377534 | 0.84[ASN][1000 genomes] |
rs378757 | 0.84[ASN][1000 genomes] |
rs379662 | 0.86[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs379677 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs379793 | 1.00[ASN][1000 genomes] |
rs380432 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs380872 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs381605 | 0.84[AFR][1000 genomes] |
rs381697 | 1.00[ASN][1000 genomes] |
rs381831 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs383038 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs3867194 | 0.84[ASN][1000 genomes] |
rs3867195 | 0.84[ASN][1000 genomes] |
rs386969 | 0.84[AFR][1000 genomes] |
rs388321 | 0.84[AFR][1000 genomes] |
rs388994 | 0.84[ASN][1000 genomes] |
rs390936 | 0.84[ASN][1000 genomes] |
rs393723 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs396748 | 1.00[ASN][1000 genomes] |
rs397659 | 0.84[ASN][1000 genomes] |
rs397742 | 0.92[ASN][1000 genomes] |
rs399611 | 0.84[ASN][1000 genomes] |
rs401060 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs4026047 | 0.84[ASN][1000 genomes] |
rs4026060 | 0.84[ASN][1000 genomes] |
rs4026061 | 0.84[ASN][1000 genomes] |
rs4026075 | 0.84[ASN][1000 genomes] |
rs402744 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs403107 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs405780 | 0.86[AFR][1000 genomes];0.83[ASN][1000 genomes] |
rs407762 | 0.81[AFR][1000 genomes] |
rs410827 | 0.84[AFR][1000 genomes] |
rs416612 | 0.84[AFR][1000 genomes] |
rs417499 | 0.84[AFR][1000 genomes] |
rs418388 | 0.84[AFR][1000 genomes] |
rs420639 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs422367 | 0.84[ASN][1000 genomes] |
rs423379 | 0.86[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs423952 | 0.84[AFR][1000 genomes] |
rs423985 | 0.84[ASN][1000 genomes] |
rs425249 | 0.82[AFR][1000 genomes];0.92[ASN][1000 genomes] |
rs427017 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs428385 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs428980 | 0.84[ASN][1000 genomes] |
rs432119 | 0.84[AFR][1000 genomes] |
rs432839 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs436200 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs436921 | 0.84[ASN][1000 genomes] |
rs437812 | 0.84[ASN][1000 genomes] |
rs441567 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs441874 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs441887 | 0.84[ASN][1000 genomes] |
rs442442 | 0.84[ASN][1000 genomes] |
rs442635 | 0.84[AFR][1000 genomes] |
rs443899 | 0.84[ASN][1000 genomes] |
rs444905 | 0.84[ASN][1000 genomes] |
rs445408 | 0.84[ASN][1000 genomes] |
rs445991 | 0.82[AFR][1000 genomes] |
rs446398 | 0.84[ASN][1000 genomes] |
rs446712 | 0.84[AFR][1000 genomes] |
rs446784 | 1.00[ASN][1000 genomes] |
rs446838 | 0.82[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs449866 | 0.84[ASN][1000 genomes] |
rs451441 | 0.84[ASN][1000 genomes] |
rs452446 | 0.92[ASN][1000 genomes] |
rs452453 | 0.84[AFR][1000 genomes] |
rs55795389 | 0.84[ASN][1000 genomes] |
rs55946377 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs56015102 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs56039011 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs57878888 | 0.86[AFR][1000 genomes] |
rs57910065 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs581768 | 1.00[ASN][1000 genomes] |
rs58207985 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs582295 | 1.00[ASN][1000 genomes] |
rs58638426 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs587132 | 0.84[AFR][1000 genomes] |
rs587212 | 0.84[AFR][1000 genomes] |
rs592822 | 0.84[ASN][1000 genomes] |
rs59765058 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs598554 | 0.84[AFR][1000 genomes] |
rs599458 | 0.84[AFR][1000 genomes] |
rs599536 | 0.84[AFR][1000 genomes] |
rs604552 | 0.84[ASN][1000 genomes] |
rs60469577 | 0.82[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs604719 | 0.84[ASN][1000 genomes] |
rs606501 | 0.84[AFR][1000 genomes];0.85[ASN][1000 genomes] |
rs61177778 | 0.89[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs61416021 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs62106005 | 0.87[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62123849 | 0.82[AMR][1000 genomes];0.95[EUR][1000 genomes] |
rs62123853 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62123854 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62123855 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62123856 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62123858 | 0.96[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62123859 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62125574 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs624928 | 0.81[AFR][1000 genomes] |
rs648941 | 0.84[AFR][1000 genomes] |
rs648964 | 0.84[AFR][1000 genomes] |
rs649276 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs652215 | 0.82[AFR][1000 genomes] |
rs652223 | 0.84[AFR][1000 genomes] |
rs652538 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs652570 | 0.84[AFR][1000 genomes] |
rs661487 | 0.84[AFR][1000 genomes] |
rs661895 | 0.84[AFR][1000 genomes] |
rs662391 | 0.84[AFR][1000 genomes] |
rs66478629 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs666312 | 0.84[AFR][1000 genomes] |
rs666382 | 0.84[AFR][1000 genomes] |
rs668184 | 0.84[AFR][1000 genomes] |
rs66914933 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs67340034 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs67452168 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs67501846 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs67666680 | 0.84[ASN][1000 genomes] |
rs67816767 | 0.84[ASN][1000 genomes] |
rs67914199 | 0.84[ASN][1000 genomes] |
rs679834 | 0.84[AFR][1000 genomes] |
rs7245851 | 1.00[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7246069 | 0.95[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7246079 | 0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7246426 | 0.96[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7246470 | 0.97[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7246581 | 0.97[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7246796 | 0.95[AFR][1000 genomes];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7246937 | 0.97[AFR][1000 genomes];0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7246956 | 1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7247134 | 0.93[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7247466 | 0.97[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7251588 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7251612 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73007004 | 0.84[ASN][1000 genomes] |
rs73007032 | 0.84[ASN][1000 genomes] |
rs73007842 | 0.89[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs73007847 | 0.91[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs73007849 | 1.00[ASN][1000 genomes] |
rs73009707 | 1.00[ASN][1000 genomes] |
rs73009718 | 1.00[ASN][1000 genomes] |
rs73009738 | 1.00[ASN][1000 genomes] |
rs73020070 | 0.84[ASN][1000 genomes] |
rs73530585 | 0.84[ASN][1000 genomes] |
rs7507484 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs7507509 | 0.84[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs9783961 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs9783963 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs9783965 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
rs9783966 | 0.88[AFR][1000 genomes];1.00[ASN][1000 genomes] |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv911325 | chr19:20151257-21071548 | ZNF genes & repeats Active TSS Weak transcription Flanking Active TSS Genic enhancers Strong transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 49 gene(s) | inside rSNPs | diseases |
2 | nsv530804 | chr19:20574295-21001349 | Weak transcription Strong transcription Active TSS ZNF genes & repeats Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 21 gene(s) | inside rSNPs | diseases |
3 | nsv1065039 | chr19:20818886-20977326 | Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Strong transcription ZNF genes & repeats Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
4 | esv2751781 | chr19:20818886-20985425 | ZNF genes & repeats Enhancers Weak transcription Strong transcription Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
5 | nsv578921 | chr19:20818886-20985425 | ZNF genes & repeats Weak transcription Active TSS Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
6 | nsv458510 | chr19:20818886-20987550 | Flanking Active TSS ZNF genes & repeats Weak transcription Strong transcription Active TSS Genic enhancers Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
7 | nsv578910 | chr19:20818886-20987550 | Weak transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Active TSS Strong transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
8 | nsv578917 | chr19:20818886-20989873 | Weak transcription ZNF genes & repeats Active TSS Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 10 gene(s) | inside rSNPs | diseases |
9 | nsv578918 | chr19:20818886-21008212 | ZNF genes & repeats Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
10 | esv3447275 | chr19:20818886-21030779 | Strong transcription Weak transcription ZNF genes & repeats Enhancers Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
11 | esv2752729 | chr19:20818886-21169554 | ZNF genes & repeats Weak transcription Strong transcription Enhancers Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
12 | nsv1062776 | chr19:20818886-21273361 | Weak transcription Active TSS Enhancers ZNF genes & repeats Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
13 | nsv932110 | chr19:20818886-21278952 | Weak transcription ZNF genes & repeats Enhancers Active TSS Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
14 | esv2763043 | chr19:20818886-21290543 | Weak transcription Flanking Active TSS Enhancers ZNF genes & repeats Strong transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
15 | nsv1061771 | chr19:20845947-20965419 | Flanking Active TSS Strong transcription Weak transcription Active TSS ZNF genes & repeats Enhancers Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
16 | nsv1056879 | chr19:20845947-20973432 | Enhancers Active TSS ZNF genes & repeats Flanking Active TSS Strong transcription Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
17 | nsv1058458 | chr19:20845947-20975268 | Weak transcription ZNF genes & repeats Active TSS Strong transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
18 | nsv1067183 | chr19:20845947-20975268 | Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
19 | nsv1055911 | chr19:20845947-20977326 | Weak transcription Active TSS Enhancers ZNF genes & repeats Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
20 | nsv1059582 | chr19:20845947-20977326 | Weak transcription Strong transcription Active TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
21 | nsv1064916 | chr19:20845947-20977326 | Weak transcription Active TSS ZNF genes & repeats Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
22 | nsv1065495 | chr19:20845947-20977326 | Weak transcription Strong transcription Active TSS ZNF genes & repeats Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
23 | nsv1067256 | chr19:20845947-20980301 | Strong transcription Enhancers ZNF genes & repeats Flanking Active TSS Weak transcription Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
24 | esv2830042 | chr19:20845947-20980958 | Active TSS ZNF genes & repeats Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
25 | nsv458513 | chr19:20845947-20980958 | Strong transcription Flanking Active TSS Weak transcription ZNF genes & repeats Enhancers Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
26 | nsv578929 | chr19:20845947-20980958 | Active TSS Enhancers ZNF genes & repeats Weak transcription Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
27 | nsv1063556 | chr19:20845947-20981129 | ZNF genes & repeats Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
28 | nsv1065960 | chr19:20845947-20981129 | Weak transcription Active TSS Strong transcription ZNF genes & repeats Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
29 | nsv578930 | chr19:20845947-20982627 | Active TSS Weak transcription ZNF genes & repeats Enhancers Strong transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
30 | esv2751782 | chr19:20845947-20985460 | ZNF genes & repeats Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
31 | nsv1066747 | chr19:20845947-20985924 | Weak transcription Enhancers Active TSS ZNF genes & repeats Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
32 | nsv1060429 | chr19:20845947-20986303 | ZNF genes & repeats Enhancers Weak transcription Strong transcription Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
33 | nsv1060579 | chr19:20845947-20986303 | Weak transcription Strong transcription ZNF genes & repeats Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
34 | nsv1061028 | chr19:20845947-20986303 | Weak transcription Enhancers ZNF genes & repeats Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
35 | nsv1061596 | chr19:20845947-20986303 | Active TSS Strong transcription Enhancers Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
36 | nsv1062051 | chr19:20845947-20986303 | Weak transcription Strong transcription Flanking Active TSS ZNF genes & repeats Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
37 | nsv1063760 | chr19:20845947-20986303 | Active TSS Enhancers ZNF genes & repeats Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
38 | nsv1066131 | chr19:20845947-20986303 | Strong transcription Active TSS ZNF genes & repeats Weak transcription Flanking Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
39 | esv3693420 | chr19:20845947-20987550 | Weak transcription ZNF genes & repeats Enhancers Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
40 | nsv517256 | chr19:20845947-20987550 | Strong transcription ZNF genes & repeats Enhancers Weak transcription Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
41 | nsv458514 | chr19:20845947-20987550 | Active TSS ZNF genes & repeats Enhancers Strong transcription Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
42 | nsv458515 | chr19:20845947-20987550 | Enhancers Active TSS ZNF genes & repeats Weak transcription Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
43 | nsv458516 | chr19:20845947-20987550 | Strong transcription Weak transcription Active TSS ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
44 | nsv458517 | chr19:20845947-20987550 | Active TSS Weak transcription Strong transcription Enhancers ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
45 | nsv458519 | chr19:20845947-20987550 | Strong transcription Weak transcription ZNF genes & repeats Enhancers Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
46 | nsv458520 | chr19:20845947-20987550 | Weak transcription Active TSS Bivalent/Poised TSS ZNF genes & repeats Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
47 | nsv458521 | chr19:20845947-20987550 | ZNF genes & repeats Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
48 | nsv458522 | chr19:20845947-20987550 | Bivalent Enhancer ZNF genes & repeats Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
49 | nsv458523 | chr19:20845947-20987550 | ZNF genes & repeats Strong transcription Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
50 | nsv578923 | chr19:20845947-20987550 | Strong transcription Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:20958600-20960000 | Active TSS | Primary T cells from cord blood | blood |
2 | chr19:20958800-20959200 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr19:20958800-20959200 | Active TSS | Monocytes-CD14+_RO01746 | blood |
4 | chr19:20958800-20959400 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr19:20958800-20959600 | Active TSS | Primary B cells from cord blood | blood |
6 | chr19:20958800-20959600 | Active TSS | Fetal Muscle Trunk | muscle |
7 | chr19:20958800-20959800 | Active TSS | Primary monocytes fromperipheralblood | blood |
8 | chr19:20958800-20959800 | Active TSS | Primary T regulatory cells fromperipheralblood | blood |
9 | chr19:20958800-20959800 | Active TSS | Duodenum Smooth Muscle | Duodenum |
10 | chr19:20958800-20959800 | Active TSS | Gastric | stomach |
11 | chr19:20958800-20960000 | Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
12 | chr19:20958800-20960000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr19:20958800-20960000 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr19:20958800-20960000 | Active TSS | Primary T helper cells PMA-I stimulated | -- |
15 | chr19:20958800-20960000 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr19:20958800-20960000 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
17 | chr19:20958800-20960000 | Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
18 | chr19:20958800-20960000 | Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr19:20958800-20960000 | Active TSS | Brain Angular Gyrus | brain |
20 | chr19:20958800-20960000 | Active TSS | Brain Anterior Caudate | brain |
21 | chr19:20958800-20960000 | Active TSS | Brain Cingulate Gyrus | brain |
22 | chr19:20958800-20960000 | Active TSS | Brain Hippocampus Middle | brain |
23 | chr19:20958800-20960000 | Active TSS | Brain Inferior Temporal Lobe | brain |
24 | chr19:20958800-20960000 | Active TSS | Duodenum Mucosa | Duodenum |
25 | chr19:20958800-20960000 | Active TSS | Fetal Lung | lung |
26 | chr19:20958800-20960000 | Active TSS | HSMM | muscle |
27 | chr19:20958800-20960000 | Active TSS | NHEK | skin |
28 | chr19:20958800-20960200 | Active TSS | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
29 | chr19:20958800-20960200 | Flanking Active TSS | Primary neutrophils fromperipheralblood | blood |
30 | chr19:20958800-20960200 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
31 | chr19:20958800-20960200 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
32 | chr19:20958800-20960200 | Active TSS | Brain Germinal Matrix | brain |
33 | chr19:20958800-20960200 | Active TSS | Fetal Kidney | kidney |
34 | chr19:20958800-20960200 | Active TSS | Rectal Mucosa Donor 29 | rectum |
35 | chr19:20958800-20960200 | Active TSS | Thymus | Thymus |
36 | chr19:20958800-20960200 | Active TSS | NH-A | brain |
37 | chr19:20958800-20960200 | Active TSS | NHLF | lung |
38 | chr19:20958800-20960200 | Active TSS | Osteobl | bone |
39 | chr19:20958800-20960400 | Active TSS | Ganglion Eminence derived primary cultured neurospheres | brain |
40 | chr19:20958800-20960400 | Active TSS | Fetal Brain Female | brain |
41 | chr19:20959000-20959200 | Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
42 | chr19:20959000-20959200 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
43 | chr19:20959000-20959200 | Active TSS | Primary T helper naive cells fromperipheralblood | blood |
44 | chr19:20959000-20959200 | Active TSS | Primary T helper 17 cells PMA-I stimulated | -- |
45 | chr19:20959000-20959200 | Active TSS | Primary mononuclear cells fromperipheralblood | Blood |
46 | chr19:20959000-20959200 | Active TSS | Adipose Nuclei | Adipose |
47 | chr19:20959000-20959200 | Active TSS | Dnd41 | blood |
48 | chr19:20959000-20959200 | Active TSS | HepG2 | liver |
49 | chr19:20959000-20959400 | Active TSS | Primary T helper cells fromperipheralblood | blood |
50 | chr19:20959000-20959400 | Active TSS | Skeletal Muscle Female | skeletal muscle |